MedTrace Logo

Blood Levels of Tumor Cells in Predicting Response in Patients Receiving First-Line Chemotherapy for Stage IV Breast Cancer

NCT00898014 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 216

Last updated 2011-05-13

No results posted yet for this study

Summary

RATIONALE: Measuring blood levels of tumor cells in patients with breast cancer may help doctors predict how patients will respond to treatment.

PURPOSE: This laboratory study is looking at blood levels of tumor cells in predicting response in patients receiving first-line chemotherapy for stage IV breast cancer.

Conditions

Interventions

GENETIC

fluorescence in situ hybridization

OTHER

immunologic technique

OTHER

laboratory biomarker analysis

Sponsors & Collaborators

  • Institut Curie

    lead OTHER

Principal Investigators

  • Jean-Yves Pierga, MD, PhD · Institut Curie

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2010-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898014 on ClinicalTrials.gov